Glycorex Transplantation AB (publ): Interim Report January - September 2023
July – September 2023 · Net sales: SEK 6.2 million (8.8) · Operating income: SEK -5.4 million (-0.8) · Net income for the period: SEK -5.5 million (-0.8) · Earnings per share: SEK -0.07 (-0.01) January – September 2023 · Net sales: SEK 22.3 million (26.8) · Operating income: SEK -13.6 million (-6.5) · Net income for the period: SEK -13.7 million (-6.6) · Earnings per share: SEK -0.19 (-0.09) Summary of the quarter · The number of units sold decreased by 13%, and the turnover decreased by 30% due to weaker sales to some of our major European markets,